Results 361 to 370 of about 4,600,401 (406)

Anticoagulation therapy

British Journal of Hospital Medicine, 2008
Every junior doctor will have to prescribe some form of anticoagulation therapy for their patients. Foundation year 1 doctors should be familiar with the use of warfarin and heparin as anticoagulants, and be able to prescribe them appropriately, safely and effectively. The use of these drugs is outlined here.
R, Shakur   +3 more
openaire   +2 more sources

Relationship of Anticoagulant Therapy With Cognitive Impairment Among Patients With Atrial Fibrillation: A Meta‐Analysis and Systematic Review

Journal of Cardiovascular Pharmacology, 2018
Background: At present, it is considered that atrial fibrillation (AF) is a risk factor for cognitive impairment and dementia. It is independent of stroke, but the relationship between anticoagulant drugs and cognitive function in patients with AF is ...
Wenke Cheng   +3 more
semanticscholar   +1 more source

Anticoagulation Therapy in Children

Seminars in Thrombosis and Hemostasis, 2003
Thromboembolic events (TEs) in children are rare but are becoming a recognized cause of morbidity and mortality, particularly in children with serious underlying primary conditions such as congenital heart disease, cancer, or prematurity. Neonates, infants, and adolescents are most at risk for developing TEs among children, and the presence of a ...
Anthony K.C. Chan, Shoshana Revel-Vilk
openaire   +6 more sources

Anticoagulation clinics and the monitoring of anticoagulant therapy

International Journal of Cardiology, 1988
Patients attending an anticoagulation clinic were studied to delineate predisposing risk factors for bleeding and thromboembolic episodes. Seventy-three patients were observed for a total of 921.8 patient-treatment months. The mean duration of treatment was 12.6 months (range 3-36 months).
Richard Charney   +3 more
openaire   +3 more sources

The evolution of anticoagulant therapy.

Blood transfusion = Trasfusione del sangue, 2016
Arterial and venous thromboembolism are leading causes of morbidity and mortality around the world. For almost 70 years, heparins (unfractionated heparin and low molecular weight heparins) and vitamin K antagonists have been the leading therapeutic ...
M. Franchini   +3 more
semanticscholar   +1 more source

Anticoagulation Therapy in Children [PDF]

open access: possibleSeminars in Thrombosis and Hemostasis, 2017
AbstractVenous thromboembolism (VTE) is very uncommon in children and adolescents compared with older adults, though its incidence has significantly increased over the past two decades. Given the rarity of the condition, the data on pediatric VTE lag behind the adult experience and consequently the management of VTE in children is, in large part ...
openaire   +2 more sources

Anticoagulant therapy with ancrod

Critical Reviews in Oncology/Hematology, 1993
5.7. 5.8 ......... . . Treatment of venous thromboembolism 5.1.1. Deep venous thrombosis 5.1.2. Pulmonaryembolus Prophylaxis of venous thromboembolism Other venous thrombotic disorders Treatment of arterial thromboembolism 5.4.
Jeffrey S. Ginsberg, R.L. Soutar
openaire   +3 more sources

Home - About - Disclaimer - Privacy